Education

PhD, Université Claude Bernard Lyon 1/INSERM U1111, France, 2016

Current position

Post-doctoral fellow, Cell and Developmental Biology, University of Michigan/Medical School, USA

Publications

1. Maroui, M. A., Calle, A., Cohen, C., Streichenberger, N., Texier, P., Takissian, J., Rousseau, A., Poccardi, N., Welsch, J., Corpet, A., Schaeffer, L., Labetoulle, M. and Lomonte, P. (2016). Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment. PLoS Pathog 12(9): e1005834.
2. Figueira, T. N., Palermo, L. M., Veiga, A. S., Huey, D., Alabi, C. A., Santos, N. C., Welsch, J. C., Mathieu, C., Horvat, B., Niewiesk, S., Moscona, A., Castanho, M. A. R. B. and Porotto, M. (2016). In vivo efficacy of measles virus fusion protein-derived peptides is modulated by properties of self-assembly and membrane residence. J Virol 01554-16.
3. Bloyet, L. M., Welsch, J., Enchery, F., Mathieu, C., de Breyne, S., Horvat, B., Grigorov, B. and Gerlier, D. (2016). HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases. J Virol 90(15): 6642-6656.
4. Mathieu, C., Huey, D., Jurgens, E., Welsch, J. C., DeVito, I., Talekar, A., Horvat, B., Niewiesk, S., Moscona, A. and Porotto, M. (2015). Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides. J Virol 89(2): 1143-1155.
5. Reynaud, J. M., Jégou, J. F., Welsch, J. C. and Horvat, B. (2014). Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9. J Virol 88: 5421–36.
6. Welsch, J. C., Talekar, A., Mathieu, C., Pessi, A., Moscona, A., Horvat, B. and Porotto, M. (2013). Fatal measles virus infection prevented by brain-penetrant fusion inhibitors. J Virol 87(24): 13785-13794.